Pancreatic Cancer

Posted On 2017-01-12 18:10:08
Pancreatic Cancer
Editors: Yupei Zhao; Lei Zheng
Publisher: AME Publishing Company (2015)
ISBN-13: 978-9881402776
Hardcover: 461 pages
Language: English
Available at:
Pancreatic cancer remains to be a challenge for the health care providers in the world. For the past three decades, we have made few breakthroughs for managing this malignant disease. Unless a breakthrough would be made in the near future, as projected, pancreatic cancer would become the second leading cause of death from cancer diseases in the United States by 2020. The contributions of the clinicians and clinical researches to the field of pancreatic cancer have revolutionized the entire medicine and surgery field. Many chapters of this book have testified the importance of the advancements in the management of pancreatic cancer as landmarks in the history of medicine and surgery.

Editors

Yupei Zhao Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
Lei Zheng Departments of Oncology, Surgery; The Sidney Kimmel Cancer Center; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; The Sol Goldman Pancreatic Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

Associate Editors

Taiping Zhang Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
Barish H. Edil Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
Matthew J. Weiss Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Jin He Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
Table of Contents
Preface
Epidemiology of pancreatic cancer
1 Pancreatic cancer incidence and mortality patterns in China, 2011
Yutong He, Rongshou Zheng, Daojuan Li, Hongmei Zeng, Siwei Zhang, Wanqing Chen
10 Glucose intolerance and the risk of pancreatic cancer
Miho Ito, Naohiko Makino, Yoshiyuki Ueno
Pathology of pancreatic cancer
17 Pancreatic adenocarcinoma pathology: changing “landscape”
Lodewijk A. A. Brosens, Wenzel M. Hackeng, G. Johan Offerhaus, Ralph H. Hruban, Laura D. Wood
34 The role of epithelial-mesenchymal transition in pancreatic cancer
Jen-Jung Pan, Muh-Hwa Yang
40 Histamine regulation of pancreatitis and pancreatic cancer: a review of recent findings
Taylor Francis, Allyson Graf, Kyle Hodges, Lindsey Kennedy, Laura Hargrove, Mattie Price, Kate Kearney, Heather Francis
Diagnostic methods of pancreatic cancer
51 Imaging preoperatively for pancreatic adenocarcinoma
Jason Alan Pietryga, Desiree E. Morgan
66 Imaging of pancreatic cancer: an overview
Pavan Tummala, Omer Junaidi, Banke Agarwal
73 Endoscopic ultrasonography for pancreatic cancer: current and future perspectives
Claudio De Angelis, Rosario Francesco Brizzi, Rinaldo Pellicano
85 Delayed diagnosis of pancreatic cancer reported as more common in a population of North African young adults
Feriel Sellam, Noria Harir, Méghit B. Khaled, Nesrine M. Mrabent, Rachida Salah, Arslane Benchouk, Mustapha Diaf

more

Treatment of pancreatic cancer
91 Pancreatic cancer surgery: past, present, and future
James F. Griffin, Katherine E. Poruk, Christopher L. Wolfgang
108 Current surgical management of pancreatic cancer
Charles B. Kim, Shuja Ahmed, Eddy C. Hsueh
119 Surgical treatment of pancreatic head cancer: concept revolutions and arguments
Zhe Cao, Jianwei Xu, Qianqian Shao, Taiping Zhang, Yupei Zhao
124 Pancreatic cancer surgery and nutrition management: a review of the current literature
Cheguevara Afaneh, Deborah Gerszberg, Eoin Slattery, David S. Seres, John A. Chabot, Michael D. Kluger
137 Preoperative therapies for resectable and borderline resectable pancreatic cancer
Gauri R. Varadhachary
144 Management of periampullary adenocarcinoma by pancreaticoduodenectomy at a regional teaching hospital
Brian McKinley, Simon Lehtinen, Scott Davis, Justin Collins, Dawn Blackhurst, Christine Marie-Gilligan Schammel, David P. Schammel, Steven D. Trocha
151 Robotic pancreaticoduodenectomy for pancreatic adenocarcinoma: role in 2014 and beyond
Erin H. Baker, Samuel W. Ross, Ramanathan Seshadri, Ryan Z. Swan, David A. Iannitti, Dionisios Vrochides, John B. Martinie
161 Laparoscopic distal pancreatectomy for adenocarcinoma: safe and reasonable?
Lauren M. Postlewait, David A. Kooby
173 Can pancreaticoduodenectomy performed at a comprehensive community cancer center have comparable results as major tertiary center?
Charles Cheng, David Duppler, Boguslawa Koczon Jaremko
181 Outcomes of resected pancreatic cancer in patients age ≥70
Thomas J. Hayman, Tobin Strom, Gregory M. Springett, Lodovico Balducci, Sarah E. Hoffe, Kenneth L. Meredith, Pamela Hodul, Mokenge Malafa, Ravi Shridhar
188 Pancreatic fistula and postoperative pancreatitis after pancreatoduodenectomy for pancreatic cancer
Miroslav Ryska, Jan Rudis
196 Laparoscopic pancreaticoduodenectomy: a descriptive and comparative review
Justin Merkow, Alessandro Paniccia, Barish H. Edil
204 Surgery for oligometastasis of pancreatic cancer
Fengchun Lu, Katherine E. Poruk, Matthew J. Weiss
214 Current status and future direction of chemotherapy for pancreatic cancer
Junji Furuse, Fumio Nagashima
221 Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis
Aline da Rocha Lino, Carina Meira Abrahão, Raphael Moreira Brandão, Jessica Ribeiro Gomes, Andrea Malta Ferrian, Marcel Cerqueira César Machado, Antonio Carlos Buzaid, Fernando Cotait Maluf, Renata D’Alpino Peixoto
226 Intraperitoneal gemcitabine chemotherapy as an adjuvant treatment for patients with resected pancreatic cancer: phase II and pharmacologic studies
Paul H. Sugarbaker, O. Anthony Stuart, Lana Bijelic
234 Advances of stereotactic body radiotherapy in pancreatic cancer
Qichun Wei, Wei Yu, Lauren M. Rosati, Joseph M. Herman
243 The role of radiotherapy in management of pancreatic cancer
Fen Wang, Parvesh Kumar
255 Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions
Aaron T. Wild, Susan M. Hiniker, Daniel T. Chang, Phuoc T. Tran, Mouen A. Khashab, Maneesha R. Limaye, Daniel A. Laheru, Dung T. Le, Rachit Kumar, Jonathan S. Pai, Blaire Hargens, Andrew B. Sharabi, Eun Ji Shin, Lei Zheng, Timothy M. Pawlik, Christopher L. Wolfgang, Albert C. Koong, Joseph M. Herman
264 Evaluation of normal tissue exposure in patients receiving radiotherapy for pancreatic cancer based on RTOG 0848
Ted C. Ling, Jerry M. Slater, Rachel Mifflin, Prashanth Nookala, Roger Grove, Anh M. Ly, Baldev Patyal, Jerry D. Slater, Gary Y. Yang
271 Neoadjuvant therapy for localized pancreatic cancer: guiding principles
Amir Fathi, Kathleen K. Christians, Ben George, Paul S. Ritch, Beth A. Erickson, Parag Tolat, Fabian M. Johnston, Douglas B. Evans, Susan Tsai
283 Novel adjuvant therapies for pancreatic adenocarcinoma
Tolutope Oyasiji, Wen Wee Ma
289 Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
Michael D. Chuong, Drexell H. Boggs, Kruti N. Patel, William F. Regine
301 Adjuvant radiation therapy for pancreatic cancer: a review of the old and the new
John Boyle, Brian Czito, Christopher Willett, Manisha Palta
310 Self-expanding metal stents (SEMS) provide superior outcomes compared to plastic stents for pancreatic cancer patients undergoing neoadjuvant therapy
Megan A. Adams, Michelle A. Anderson, James D. Myles, Shokoufeh Khalatbari, James M. Scheiman
315 Nanovector-based therapies in advanced pancreatic cancer
Chang-Sung Tsai, John W. Park, Li-Tzong Chen
326 Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trials
Alessandro Paniccia, Justin Merkow, Barish H. Edil, Yuwen Zhu
342 Diagnosis and management of cystic lesions of the pancreas
William R. Brugge
356 Current and future systemic treatment options in metastatic pancreatic cancer
Cagatay Arslan, Suayib Yalcin
372 Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience
Nadia K Malik, Kilian Salerno May, Rameela Chandrasekhar, Wen Wee Ma, Leayn Flaherty, Renuka Iyer, John Gibbs, Boris Kuvshinoff, Gregory Wilding, Graham Warren, Gary Y Yang
382 A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer
Shane Lloyd, Bryan W. Chang
390 Locally advanced versus metastatic pancreatic cancer: two different diseases with two different treatment approaches?
Stefano Cascinu
393 HIFU for palliative treatment of pancreatic cancer
Tatiana D. Khokhlova, Joo Ha Hwang
404 Use of irreversible electroporation in unresectable pancreatic cancer
Robert C. G. Martin II
409 Pain management of pancreatic head adenocarcinomas that are unresectable: celiac plexus neurolysis and splanchnicectomy
Wesley B. Jones, Phillip Jordan, Maya Pudi
Prognosis of pancreatic cancer
416 Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trial
Sidra Anwar, Wei Tan, Jinhee Yu, Alan Hutson, Milind Javle, Renuka Iyer
423 Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer
Gary Y. Yang, Nadia K. Malik, Rameela Chandrasekhar, Wen-Wee Ma, Leayn Flaherty, Renuka Iyer, Boris Kuvshinoff, John Gibbs, Gregory Wilding, Graham Warren, Kilian Salerno May

Click the book to view the entire PDF